Table 1.
Item | Region |
---|---|
Target population (children under 5 years) | 148,104.00 |
Number of fully dosed children | 118,208.00 |
Cost of SMC programme (US$, 2015 prices) | |
Total financial cost | 1142,040.80 |
Financial cost per fully dosed child | 9.66 (95 % CI 7.46–14.21) |
Economic cost (provider perspective) | 2663,697.18 |
Economic cost (societal perspective) | 7961,153.27 |
Effect of SMC programme | |
Additional number of cases averted | 24,881 |
Additional number of child deaths averted | 808 |
Cost-effectiveness ratios (ICERs) (US$, 2015 prices) | |
Provider perspectivea | |
Economic cost per fully dosed child | 22.53 (95 % CI 21.08–28.06) |
Economic cost per additional case averted | 107.06 (95 % CI 99.75–121.48) |
Economic cost per additional child death averted | 3298.36 (95 % CI 3073.26–3742.64) |
Societal perspectiveb | |
Economic cost per fully dosed child | 67.35 (95 % CI 63.56–77.86) |
Economic cost per additional case averted | 319.96 (95 % CI 284.23–366.38) |
Economic cost per additional child death averted | 9858.02 (95 % CI 8757.11–11,288.08) |
aIncludes only provider-related costs incurred on delivery of the intervention
bIncludes cost incurred on delivery of the intervention, donations and the valued time and other expenses of caregivers and volunteers